US 12,029,772 B2
Willow extract and its use in treating a viral infection, allergic reaction, and other medical conditions
Mustafa Barzani, McLean, VA (US)
Assigned to Mustafa Barzani, McLean, VA (US); and Shireen Nature Company for General Trading Ltd., Erbil (IQ)
Filed by Mustafa Barzani, McLean, VA (US); and Shireen Nature Company for General Trading, Ltd., McLean, VA (US)
Filed on Mar. 29, 2022, as Appl. No. 17/706,865.
Claims priority of provisional application 63/323,810, filed on Mar. 25, 2022.
Claims priority of provisional application 63/279,842, filed on Nov. 16, 2021.
Claims priority of provisional application 63/167,166, filed on Mar. 29, 2021.
Prior Publication US 2022/0323531 A1, Oct. 13, 2022
Int. Cl. A61K 36/00 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 31/192 (2006.01); A61K 31/353 (2006.01); A61K 31/427 (2006.01); A61K 31/4965 (2006.01); A61K 31/513 (2006.01); A61K 31/517 (2006.01); A61K 31/675 (2006.01); A61K 31/7034 (2006.01); A61K 31/7048 (2006.01); A61K 31/7068 (2006.01); A61K 36/76 (2006.01); A61K 38/17 (2006.01); A61K 38/21 (2006.01); A61K 39/395 (2006.01); A61K 39/42 (2006.01); A61P 31/14 (2006.01)
CPC A61K 36/76 (2013.01) [A61K 9/0053 (2013.01); A61K 9/48 (2013.01); A61K 31/192 (2013.01); A61K 31/353 (2013.01); A61K 31/427 (2013.01); A61K 31/4965 (2013.01); A61K 31/513 (2013.01); A61K 31/517 (2013.01); A61K 31/675 (2013.01); A61K 31/7034 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 38/1774 (2013.01); A61K 38/21 (2013.01); A61K 39/3955 (2013.01); A61K 39/42 (2013.01); A61P 31/14 (2018.01); A61K 2236/15 (2013.01); A61K 2236/37 (2013.01); A61K 2236/39 (2013.01); A61K 2236/51 (2013.01); A61K 2236/53 (2013.01)] 28 Claims
 
1. A method of treating a condition that is a coronavirus infection in a patient, comprising orally administering to a patient in need thereof a therapeutically effective amount of a therapeutic composition comprising a willow leaf extract, to treat the condition.